| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > Accounting In Non-Profit Organisations |
|
Advice You - Accounting In Non-Profit Organisations
The nature of this type of enterprise implies that any increase in net assets arising from the activities of the undertaking must be applied to improve the communi According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ty services rendered by the specific organisation. The increase in the net assets of the entity does not accrue to the persons supporting the organisation (e.g. ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in he members). Depending on the type of undertaking, equity is usually furnished by grants from state or authorities, donations or membership fees. These contribut lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ons to equity do not confer the same rights as contributions to the equity of a limited company confer on shareholders and therefore, different accounting practise here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe apply to these enterprises. Bearing in mind the typical characteristics of a non-profit organisation, the question arises which particular requirements of accoun d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ing systems and financial reporting procedures apply to this particular type of organisation. The financial accounting must provide economically interested groups ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc with a comprehensive review of what the particular organisation achieved during a specific period or at the end of its financial accounting year. The accounting easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ecords and system developed for an economic entity must be logical and consistent and must be related to the objectives of the entity, as well as the circumstances nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically in which it conducts its activities. Because of the typical characteristics of non-profit organisations, the primary aim of accounting reporting should be to prov and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ de control over sources by means of accounting responsibility. Seeing that the function of stewardship is basic to this type of organisation and because responsib ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi lity for profit is not associated with this type of entity, most non-profit associations and organisations use the so-called funds accounting procedures for financ ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ial reporting. Funds accounting requires that the sources of finance of an organisation be divided into various funds. A fund can be defined as a sum of money or dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod other source that are set aside for a specific activity designed to achieve specific objectives and that is regarded as a separate accounting entity. The differen cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin e between this definition of a fund and the usual meaning thereof is obvious: the concept fund implies an amount of money for some other source that is intended fo tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen a specific purpose. The concept fund in a non-profit organisation embraces the additional principle of a separate accounting entity. Thus, the accounting system t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel will provide for a number of self-balancing 'fund-units' utilised in accordance with the limitations placed on the use of the funds. The funds procedure is design ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ed to prevent sources intended for a specific use from being applied for any other purpose. Funds accounting can generally be divided into two categories. (1) Re y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products enue funds - The primary use of accounting records for this type of fund is to disclose the source of the fund and the manner in which it was applied. These funds . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de are typical of those encountered in non-profit organisations. (2) Self-sustaining funds - These are fund entities that, once an initial contribution has been made elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip to them, are intended to be self-sufficient. Such funds can be considered as small profit orientated enterprises within the framework of a non-profit organisation tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Business Debt Settlement - Choosing the Right Service Provider for Business Debt Settlement Event, Conference and Meeting Planning Guidelines: 10 Steps to Success
|